Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 478-200-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- no data to 2007-04-27
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP study performed according to OECD Guideline 429 (Skin Sensitization: Local Lymph Node Assay) and EU Method B.42 (Skin Sensitization: Local Lymph Node Assay) without deviations.
Cross-reference
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 007
- Report date:
- 2007
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Remarks:
- The testing facility indicated that the protocol was followed without deviation.
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Remarks:
- The testing facility indicated that the protocol was followed without deviation.
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Department of Health of the Government of the United Kingdom
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
Reference
- Name:
- Unnamed
- Type:
- Constituent
- Details on test material:
- - Name of test material (as cited in study report): VRT-126028, P2, VRT-126028 oxalate salt
- Molecular formula (if other than submission substance): C14H23NO6
- Molecular weight (if other than submission substance): 301.34
- Smiles notation (if other than submission substance): not applicable
- InChl (if other than submission substance): not applicable
- Structural formula attached as image file (if other than submission substance): not applicable
- Substance type: no data
- Physical state: white powder
- Analytical purity: 99.3% area by GC
- Impurities (identity and concentrations): no data
- Composition of test material, percentage of components: no data
- Isomers composition: no data
- Purity test date: no data
- Lot/batch No.: Lot WYJ1141040533/Batch No. 25414
- Expiration date of the lot/batch: May 2008
- Stability under test conditions: no data
- Storage condition of test material: room temperature
- Other: Odor: slight odor
Rotation: [a]29D=+37.2 deg C (C=5515 CH3OH)
Analytical method: GC, chiral GC, NMR, Polarity, MS
Water content: 0.10% by Karl Fischer Titration
LOD: 0.03%
Residue on ignition: 0.06%
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/Ca
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan UK Ltd., Bicester, Oxon, England
- Age at study initiation: 8 to 12 weeks
- Weight at study initiation: 14.6 to 20.8 g
- Housing: individual
- Diet (e.g. ad libitum): standard laboratory rodent diet (Special Diet Services RMI (E) SQC), ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least 5 days prior to the start of the study
ENVIRONMENTAL CONDITIONS
- Temperature (deg C): 21 +/- 2 deg C
- Humidity (%): 40 to 70%
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): Lighting was controlled by means of a time switch to give 12 hours of artificial light (0600 - 1800 hours GMT) in each 24 hour period.
IN-LIFE DATES: From: no data To: no data
Study design: in vivo (LLNA)
- Vehicle:
- other: acetone:olive oil (4:1 v/v)
- Concentration:
- Preliminary and main study: 5, 10 and 25% w/v
- No. of animals per dose:
- Preliminary study: one female per dose
Main study: four females per dose - Details on study design:
- RANGE FINDING TESTS:
- Compound solubility: A vehicle trial conducted with the test substance at 50% w/v showed that it formed a thick paste in acetone:olive oil (4:1 v/v), dimethylformamide, ethyl methyl ketone, propylene glycol and dimethylsulphoxide, which were all too viscous for dose administration. In a further trial at 25% w/v in acetone:olive oil (4:1 v/v), dimethylformamide, ethyl methyl ketone, propylene glycol and dimethylsulphoxide all formed liquid suspensions which were all satisfactory for dose administration.
Acetone:olive oil (4:1 v/v) was chosen as this was the preferred vehicle from those recommended in the protocol.
- Irritation: The ears were examined for signs of irritation.
- Lymph node proliferation response: not applicable
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: The mice were allocated without conscious bias to cages within the treatment groups.
- Criteria used to consider a positive response: The test substance is regarded as a sensitizer if at least one concentration of the test substance results in a three-fold greater increase in 3HTdR incorporation compared to control values.
TREATMENT PREPARATION AND ADMINISTRATION:
Groups of four mice were treated at one of three concentrations of the test substance. The mice were treated by daily application of 25 uL of the appropriate concentration of the test substance to the dorsal surface of each ear for three consecutive days (Days 1-3). The test substance was applied to the dorsal surface of each ear using an automatic micropipette. The test substance was spread over the entire dorsal surface of the ear using the tip of the pipette. A further group of four mice received the vehicle alone in the same manner.
In the main study, five days following the first topical application of test substance (Day 6) all mice were injected via the tail vein with 250 uL of phosphate buffered saline containing 3H-methyl Thymidine (Specific activity 2.0 Ci/mmo, concentation 1.0 mCi/mL) (3HTdR: 80 uCi/ml) giving a nominal 20 uCi to each mouse. The injection into the tail vein was carried out using a plastic syringe and needle (26 gauge) after the mouse had been heated in a
warming chamber. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- no data
Results and discussion
- Positive control results:
- Disintegrations per minute
Solvent control: 2034.7
10% v/v: 16123.9
25% v/v: 27440.8
50% v/v: 40300.6
Stimulation index (test/control ratio, a stimulation index greater than 3 indicates a positive result)
Solvent control:
Not applicable
10%:
7.9
25% v/v
13.5
50% v/v
19.8
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Remarks on result:
- other: Vehicle control: not applicable 5% w/v: 1.1 10% w/v: 1.7 25% w/v: 0.6
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: Vehicle control: 1288.95 5% w/v: 1442.35 10% w/v: 2170.05 25% w/v: 729.25
Any other information on results incl. tables
PRELIMINARY STUDY
Mortality and clinical signs:
There were no deaths during the study. Clinical signs of reaction to treatment comprised:
Group 1 (5% w/v): Greasy fur around the cranial region was seen post dose from Day 1 and was still present at termination on Day 4. In addition, particles on the ears were seen post dose from Day 2; this reaction had resolved by Day 4.
Group 2 (10% w/v): Greasy fur around the cranial region was seen post dose from Day 1 and was still present at termination on Day 4. In addition, dose residue or particles on the ears were seen post dose from Day 1; this reaction had resolved by Day 4.
Group 3 (25% w/v): Particles and dose residue were seen post dose from Day 1 and test substance staining (white) was observed post dose from Day 2. In addition, greasy fur around the cranial region was noted on Day 3 only. Additional signs had resolved by termination on Day 4.
Bodyweight:
A loss in bodyweight was recorded for the female in Group 2 and no bodyweight gain was seen in the female from Group1 during the preliminary study. The remaining animals from Group 3 gained weight during the study. On the basis of the results of the preliminary study, 25% w/v was considered a suitable high dose level for the main study.
MAIN STUDY
Mortality and clinical signs:
- There were no deaths and no signs of ill health or toxicity observed during this study.
- No signs of irritation were seen over the dosed area during the study.
Greasy fur was noted for all control and test animals post-dose from Day 1. This sign had resolved completely in all animals by Day 5. Wet fur-cranial region was noted for one animal post dose from the control group on Day 1 only. Particles on the ears were seen in some animals from each of Groups 2, 3 and 4; this sign had resolved by day 4. Dose residue was seen in all animals in Group 4 from either Day 1 or 2 after dosing, and had resolved by Day 4. Test substance staining (white) over the dosed area was noted for one animal on Day 1 only. In addition, yellow staining on bedding was observed from Day 3 for all animals in Groups 2, 3 and 4.
Bodyweight:
A loss of bodyweights was recorded for one female in Group 2, one female in Group 3 and three females from Group 4 during the study. In addition, there was no bodyweight gain for one animal from Group 1. All remaining animals gained weight during the study.
Applicant's summary and conclusion
- Conclusions:
- The test substance is not regarded as a potential skin sensitizer.
- Executive summary:
Not applicable
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.